Systemic infusion of autologous adipose tissue-derived mesenchymal stem cells in peritoneal dialysis patients: feasibility and safety
Cell Journal [Yakhteh]. 2019; 20 (4): 483-495
en Inglés
| IMEMR
| ID: emr-199617
ABSTRACT
Objective:
Using mesenchymal stem cells [MSCs] is regarded as a new therapeutic approach for improving fibrotic diseases.The aim of this study to evaluate the feasibility and safety of systemic infusion of autologous adipose tissue-derived MSCs [AD-MSCs] in peritoneal dialysis [PD] patients with expected peritoneal fibrosis
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Inglés
Revista:
Cell J. [Yakhteh]
Año:
2019
Similares
MEDLINE
...
LILACS
LIS